These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22826518)

  • 21. Remimazolam should be antagonized by an adequate flumazenil.
    Sato T; Nishiwaki K
    J Anesth; 2023 Feb; 37(1):164-165. PubMed ID: 36197518
    [No Abstract]   [Full Text] [Related]  

  • 22. [Midazolam in children. Alternative routes of administration].
    Saltanov AI; Barkhudarova NCh; Illarionov IuV; Matinian NV; Ordukhanian ZS
    Anesteziol Reanimatol; 2007; (1):66-70. PubMed ID: 17460996
    [No Abstract]   [Full Text] [Related]  

  • 23. Awaiting remimazolam guidance.
    Wootton J; Forrest M
    Br Dent J; 2023 Jan; 234(2):73. PubMed ID: 36707554
    [No Abstract]   [Full Text] [Related]  

  • 24. Predicting the amount of flumazenil needed to antagonize remimazolam.
    Aya D; Hoshi T; Yamaguchi H
    Eur J Gastroenterol Hepatol; 2021 Oct; 33(10):1335-1336. PubMed ID: 34581692
    [No Abstract]   [Full Text] [Related]  

  • 25. Tolerance to remimazolam at a high effect-site concentration.
    Kida K; Taguchi M; Uchiyama K; Fujioka S; Tsubokawa T
    J Anesth; 2023 Feb; 37(1):168-169. PubMed ID: 36449088
    [No Abstract]   [Full Text] [Related]  

  • 26. Mixed-effects modeling of the influence of midazolam on propofol pharmacokinetics.
    Vuyk J; Lichtenbelt BJ; Olofsen E; van Kleef JW; Dahan A
    Anesth Analg; 2009 May; 108(5):1522-30. PubMed ID: 19372331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of midazolam in critically ill pediatric patients.
    Nahara MC; McMorrow J; Jones PR; Anglin D; Rosenberg R
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):219-21. PubMed ID: 11420893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propofol reduces the distribution and clearance of midazolam.
    Lichtenbelt BJ; Olofsen E; Dahan A; van Kleef JW; Struys MM; Vuyk J
    Anesth Analg; 2010 Jun; 110(6):1597-606. PubMed ID: 20435936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoconazole interaction in rats.
    Vuppugalla R; Zhang Y; Chang S; Rodrigues AD; Marathe PH
    Xenobiotica; 2012 Nov; 42(11):1058-68. PubMed ID: 22574883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzodiazepine hypnotics: sorting the pharmacokinetic facts.
    Greenblatt DJ
    J Clin Psychiatry; 1991 Sep; 52 Suppl():4-10. PubMed ID: 1680125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
    Walzer M; Bekersky I; Blum RA; Tolbert D
    Pharmacotherapy; 2012 Apr; 32(4):340-53. PubMed ID: 22422635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics of midazolam and its main metabolite 1-hydroxymidazolam in intensive care patients.
    Boulieu R; Lehmann B; Salord F; Fisher C; Morlet D
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):255-8. PubMed ID: 9725490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Useful information about the pharmacokinetics and pharmacodynamics of midazolam and lorazepam.
    Deem S
    Anesthesiology; 2002 Aug; 97(2):522; author reply 522-3. PubMed ID: 12151951
    [No Abstract]   [Full Text] [Related]  

  • 34. Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.
    Aoyama T; Hirata K; Yamamoto Y; Yokota H; Hayashi H; Aoyama Y; Matsumoto Y
    J Clin Pharm Ther; 2016 Aug; 41(4):392-8. PubMed ID: 27178380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intranasal midazolam in piglets: pharmacodynamics (0.2 vs 0.4 mg/kg) and pharmacokinetics (0.4 mg/kg) with bioavailability determination.
    Lacoste L; Bouquet S; Ingrand P; Caritez JC; Carretier M; Debaene B
    Lab Anim; 2000 Jan; 34(1):29-35. PubMed ID: 10759364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypnotic and sedative drugs--anything new on the horizon?
    Gin T
    Curr Opin Anaesthesiol; 2013 Aug; 26(4):409-13. PubMed ID: 23820101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam.
    Fiset P; Lemmens HL; Egan TD; Shafer SL; Stanski DR
    Clin Pharmacol Ther; 1995 Nov; 58(5):567-82. PubMed ID: 7586951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determination of medetomidine, atipamezole and midazolam in pig plasma by liquid chromatography-mass spectrometry.
    Kanazawa H; Nishimura R; Sasaki N; Takeuchi A; Takai N; Nagata Y; Matsushima Y
    Biomed Chromatogr; 1995; 9(4):188-91. PubMed ID: 8520209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anesthesia considerations in West syndrome].
    Delás Ramírez F; Navarro Egea M; Pardina Badia B
    Rev Esp Anestesiol Reanim; 2000 Dec; 47(10):493-4. PubMed ID: 11212406
    [No Abstract]   [Full Text] [Related]  

  • 40. [Are z-hypnotics better and safer sleeping pills than benzodiazepines?].
    Mellingsaeter TC; Bramness JG; Slørdal L
    Tidsskr Nor Laegeforen; 2006 Nov; 126(22):2954-6. PubMed ID: 17117195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.